Migratory phase (TB-500): TB-500 facilitates the migration of repair cells (fibroblasts, endothelial cells) toward the damaged area by modulating the actin cytoskeleton
At 0.25mg weekly, one vial lasts 12 weeks
Retatrutide vs Tirzepatide (Mounjaro): 28.7% vs 22.5% (2026 Data) Phase 3 trial comparison: Retatrutide 28.7% weight loss vs Tirzepatide 22.5%
GLP-1 injections dont replace these habits
I was very comfortable and enjoyed our conversation. Jamie "The questions are to the point and easy to navigate
nausea, vomiting, and abdominal discomfort), as well as other medical conditions that might delay gastric emptying such as Parkinsons disease, multiple sclerosis, amyloidosis, and scleroderma [19, 20]